These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

911 related items for PubMed ID: 17198973

  • 1. Blood-brain barrier delivery.
    Pardridge WM.
    Drug Discov Today; 2007 Jan; 12(1-2):54-61. PubMed ID: 17198973
    [Abstract] [Full Text] [Related]

  • 2. Blood-brain barrier genomics and the use of endogenous transporters to cause drug penetration into the brain.
    Pardridge WM.
    Curr Opin Drug Discov Devel; 2003 Sep; 6(5):683-91. PubMed ID: 14579518
    [Abstract] [Full Text] [Related]

  • 3. Targeting the brain--surmounting or bypassing the blood-brain barrier.
    Potschka H.
    Handb Exp Pharmacol; 2010 Sep; (197):411-31. PubMed ID: 20217538
    [Abstract] [Full Text] [Related]

  • 4. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?
    Juillerat-Jeanneret L.
    Drug Discov Today; 2008 Dec; 13(23-24):1099-106. PubMed ID: 18848640
    [Abstract] [Full Text] [Related]

  • 5. Molecular Trojan horses for blood-brain barrier drug delivery.
    Pardridge WM.
    Discov Med; 2006 Aug; 6(34):139-43. PubMed ID: 17234133
    [Abstract] [Full Text] [Related]

  • 6. Delivery of peptides to the brain: emphasis on therapeutic development.
    Banks WA.
    Biopolymers; 2008 Aug; 90(5):589-94. PubMed ID: 18335425
    [Abstract] [Full Text] [Related]

  • 7. Strategy for effective brain drug delivery.
    Alam MI, Beg S, Samad A, Baboota S, Kohli K, Ali J, Ahuja A, Akbar M.
    Eur J Pharm Sci; 2010 Aug 11; 40(5):385-403. PubMed ID: 20497904
    [Abstract] [Full Text] [Related]

  • 8. Delivery of drugs to the brain via the blood brain barrier using colloidal carriers.
    Tucker IG, Yang L, Mujoo H.
    J Microencapsul; 2012 Aug 11; 29(5):475-86. PubMed ID: 22563886
    [Abstract] [Full Text] [Related]

  • 9. 2B-Trans technology: targeted drug delivery across the blood-brain barrier.
    Gaillard PJ, de Boer AG.
    Methods Mol Biol; 2008 Aug 11; 437():161-75. PubMed ID: 18369968
    [Abstract] [Full Text] [Related]

  • 10. Molecular Trojan horses for blood-brain barrier drug delivery.
    Pardridge WM.
    Curr Opin Pharmacol; 2006 Oct 11; 6(5):494-500. PubMed ID: 16839816
    [Abstract] [Full Text] [Related]

  • 11. Biopharmaceutical drug targeting to the brain.
    Pardridge WM.
    J Drug Target; 2010 Apr 11; 18(3):157-67. PubMed ID: 20064077
    [Abstract] [Full Text] [Related]

  • 12. Re-engineering biopharmaceuticals for delivery to brain with molecular Trojan horses.
    Pardridge WM.
    Bioconjug Chem; 2008 Jul 11; 19(7):1327-38. PubMed ID: 18547095
    [Abstract] [Full Text] [Related]

  • 13. Modern methods for delivery of drugs across the blood-brain barrier.
    Chen Y, Liu L.
    Adv Drug Deliv Rev; 2012 May 15; 64(7):640-65. PubMed ID: 22154620
    [Abstract] [Full Text] [Related]

  • 14. The role of membrane transporters in drug delivery to brain tumors.
    Nies AT.
    Cancer Lett; 2007 Aug 28; 254(1):11-29. PubMed ID: 17275180
    [Abstract] [Full Text] [Related]

  • 15. Blood-brain barrier drug targeting: the future of brain drug development.
    Pardridge WM.
    Mol Interv; 2003 Mar 28; 3(2):90-105, 51. PubMed ID: 14993430
    [Abstract] [Full Text] [Related]

  • 16. Molecular modeling of blood-brain barrier nutrient transporters: in silico basis for evaluation of potential drug delivery to the central nervous system.
    Allen DD, Geldenhuys WJ.
    Life Sci; 2006 Feb 02; 78(10):1029-33. PubMed ID: 16126231
    [Abstract] [Full Text] [Related]

  • 17. Nanobiotechnology-based strategies for crossing the blood-brain barrier.
    Jain KK.
    Nanomedicine (Lond); 2012 Aug 02; 7(8):1225-33. PubMed ID: 22931448
    [Abstract] [Full Text] [Related]

  • 18. Hurdles with using in vitro models to predict human blood-brain barrier drug permeability: a special focus on transporters and metabolizing enzymes.
    Shawahna R, Decleves X, Scherrmann JM.
    Curr Drug Metab; 2013 Jan 02; 14(1):120-36. PubMed ID: 23215812
    [Abstract] [Full Text] [Related]

  • 19. Nanoparticles for direct nose-to-brain delivery of drugs.
    Mistry A, Stolnik S, Illum L.
    Int J Pharm; 2009 Sep 08; 379(1):146-57. PubMed ID: 19555750
    [Abstract] [Full Text] [Related]

  • 20. Targeted delivery of antibodies through the blood-brain barrier by MRI-guided focused ultrasound.
    Kinoshita M, McDannold N, Jolesz FA, Hynynen K.
    Biochem Biophys Res Commun; 2006 Feb 24; 340(4):1085-90. PubMed ID: 16403441
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.